STOCK MARKET BSE NSE

Moderna announces start of Covid-19 vaccine trials for children

We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada, said CEO Stephane Bancel in a statement.

Published: 16th March 2021 06:22 PM  |   Last Updated: 16th March 2021 06:22 PM   |  A+A-

Pharmacist Elena Schaller checks a Moderna COVID-19 vaccine in Portland, Ore., Sunday, Jan. 10, 2021. (Photo | AP)

By AFP

WASHINGTON: US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.

"We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada," said CEO Stephane Bancel in a statement.

"This pediatric study will help us assess the potential safety and immunogenicity of our Covid-19 vaccine candidate in this important younger age population."



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp